TY - JOUR
KW - Alcohol and drug abuse
KW - Mental illness and alcohol/drug abuse
AU - E. B. Jones
AU - E. M. Staab
AU - W. Wan
AU - M. T. Quinn
AU - C. Schaefer
AU - S. Gedeon
AU - A. Campbell
AU - M. H. Chin
AU - N. Laiteerapong
A1 - 
AB - OBJECTIVE: Expanding access to addiction screening and treatment in primary care, particularly in underserved communities, is a key part of the fight against the opioid epidemic. This study explored correlates of addiction treatment capacity in federally qualified health centers participating in the Midwest Clinicians' Network (MWCN). METHODS: Two surveys were fielded to 132 MWCN health centers: the Health Center Survey and the Behavioral Health and Diabetes Provider Survey. A total of 77 centers and 515 primary care clinicians, respectively, responded to the surveys. Data were combined with data from the 2016 Uniform Data System and information about receipt of targeted Health Resources and Services Administration (HRSA) grant funding for addiction treatment capacity. Multivariable models examined associations between Medicaid reimbursement for addiction services, HRSA targeted grant funding, and different types of on-site addiction treatment capacity: psychiatrist and certified addiction counselor staffing, addiction counseling services, and medication-assisted treatment (MAT) for opioid addiction. RESULTS: Health centers that received Medicaid behavioral health reimbursement were five times as likely as those that did not to offer addiction counseling and to employ certified addiction counselors. Health centers that received targeted HRSA funding for addiction services were more than 20 times as likely as those that did not to provide MAT and more than three times as likely to employ psychiatrists. Training needs and privacy protections on data related to addiction treatment were cited as barriers to building addiction treatment capacity. CONCLUSIONS: Medicaid funding and targeted grant funding were associated with addiction treatment capacity in health centers.
AD - National Institute on Drug Abuse, Rockville, Maryland, and Department of Health Policy and Management, George Washington University, Washington, D.C. (Jones); Department of Medicine, University of Chicago, Chicago (Staab, Wan, Quinn, Chin, Laiteerapong); Dunigan Family Department of Nursing and Health Sciences, University of Evansville, Evansville, Indiana (Schaefer); MidMichigan Community Health Services, Houghton Lake, Michigan (Gedeon); Midwest Clinicians' Network, East Lansing, Michigan (Campbell).; National Institute on Drug Abuse, Rockville, Maryland, and Department of Health Policy and Management, George Washington University, Washington, D.C. (Jones); Department of Medicine, University of Chicago, Chicago (Staab, Wan, Quinn, Chin, Laiteerapong); Dunigan Family Department of Nursing and Health Sciences, University of Evansville, Evansville, Indiana (Schaefer); MidMichigan Community Health Services, Houghton Lake, Michigan (Gedeon); Midwest Clinicians' Network, East Lansing, Michigan (Campbell).; National Institute on Drug Abuse, Rockville, Maryland, and Department of Health Policy and Management, George Washington University, Washington, D.C. (Jones); Department of Medicine, University of Chicago, Chicago (Staab, Wan, Quinn, Chin, Laiteerapong); Dunigan Family Department of Nursing and Health Sciences, University of Evansville, Evansville, Indiana (Schaefer); MidMichigan Community Health Services, Houghton Lake, Michigan (Gedeon); Midwest Clinicians' Network, East Lansing, Michigan (Campbell).; National Institute on Drug Abuse, Rockville, Maryland, and Department of Health Policy and Management, George Washington University, Washington, D.C. (Jones); Department of Medicine, University of Chicago, Chicago (Staab, Wan, Quinn, Chin, Laiteerapong); Dunigan Family Department of Nursing and Health Sciences, University of Evansville, Evansville, Indiana (Schaefer); MidMichigan Community Health Services, Houghton Lake, Michigan (Gedeon); Midwest Clinicians(TRUNCATED)
BT - Psychiatric services (Washington, D.C.)
C5 - Education & Workforce; Financing & Sustainability; Opioids & Substance Use
CP - 7
CY - United States
DO - 10.1176/appi.ps.201900409
IS - 7
JF - Psychiatric services (Washington, D.C.)
LA - eng
M1 - Journal Article
N2 - OBJECTIVE: Expanding access to addiction screening and treatment in primary care, particularly in underserved communities, is a key part of the fight against the opioid epidemic. This study explored correlates of addiction treatment capacity in federally qualified health centers participating in the Midwest Clinicians' Network (MWCN). METHODS: Two surveys were fielded to 132 MWCN health centers: the Health Center Survey and the Behavioral Health and Diabetes Provider Survey. A total of 77 centers and 515 primary care clinicians, respectively, responded to the surveys. Data were combined with data from the 2016 Uniform Data System and information about receipt of targeted Health Resources and Services Administration (HRSA) grant funding for addiction treatment capacity. Multivariable models examined associations between Medicaid reimbursement for addiction services, HRSA targeted grant funding, and different types of on-site addiction treatment capacity: psychiatrist and certified addiction counselor staffing, addiction counseling services, and medication-assisted treatment (MAT) for opioid addiction. RESULTS: Health centers that received Medicaid behavioral health reimbursement were five times as likely as those that did not to offer addiction counseling and to employ certified addiction counselors. Health centers that received targeted HRSA funding for addiction services were more than 20 times as likely as those that did not to provide MAT and more than three times as likely to employ psychiatrists. Training needs and privacy protections on data related to addiction treatment were cited as barriers to building addiction treatment capacity. CONCLUSIONS: Medicaid funding and targeted grant funding were associated with addiction treatment capacity in health centers.
PP - United States
PY - 2020
SN - 1557-9700; 1075-2730
SP - 684
EP - 690
EP - 
T1 - Addiction Treatment Capacity in Health Centers: The Role of Medicaid Reimbursement and Targeted Grant Funding
T2 - Psychiatric services (Washington, D.C.)
TI - Addiction Treatment Capacity in Health Centers: The Role of Medicaid Reimbursement and Targeted Grant Funding
U1 - Education & Workforce; Financing & Sustainability; Opioids & Substance Use
U2 - 32438889
U3 - 10.1176/appi.ps.201900409
VL - 71
VO - 1557-9700; 1075-2730
Y1 - 2020
Y2 - Jul 1
ER -